AMYLON

Welcome to the Brand page for “AMYLON”, which is offered here for Pharmaceuticals for treating brain conditions; pharmaceutical compositions for treating brain conditions; pharmaceutical drugs for treating brain conditions; chemico-pharmaceutical preparations for treating brain conditions; sanitary preparations for medical purposes;business fundraising for others; financial investment information; financial investment research; capital investment; venture capital funding services for inventors; venture capital funding services to emerging and start-up companies;the wording amylon has no meaning in a foreign language.;laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development in the field of biotechnology; biological research; clinical research in the field of biology and brain conditions; biomedical research services; pharmaceutical research services; research of pharmaceuticals; pharmaceutical products development; testing of pharmaceuticals; pharmaceutical drug development services; research and development of new products for the pharmaceutical industry; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “AMYLON” is believed to be currently owned by “Amylon Therapeutics BV”.